Global Neuromodulation Market Size study, by Technology (Internal Neuromodulation, External Neuromodulation), by Application (Parkinson's Disease, Epilepsy, Depression, Dystonia, Pain Management, Others) and Regional Forecasts 2020-2027
Global Neuromodulation Market is valued approximately at USD 8.1 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 13.1% over the forecast period 2020-2027. Neuromodulation is an intracranial and electrical therapy which has been approved by the Food and Drug Administration (FDA) for the treatment of the neurological diseases. Some common diseases that can be cured through neuromodulation therapy are spinal cord injury, tremors, chronic pain, minimally conscious state, bladder control, and stroke, which are usually found in the geriatric population. The proven effectiveness and enhancing acceptance of this therapy across a range of neurological disorders is expected to surge the market growth during the forecast period. As per the study of Global Burden of Disease 2015, the prevalence of Parkinson’s diseases was reported to be around 6.2 million people worldwide and it would reach approximately 13 million people with Parkinson’s by the year 2040. Also, Parkinson’s Disease Foundation reveals that nearly 60,000 Americans are diagnosed with Parkinson’s disease every year. This, in turn, is expected to create huge demand for neuromodulation devices, thereby aiding the market growth all over the world. Moreover, the rise in research activities to expand the application of neuromodulation, along with increasing awareness concerning the safety and efficacy of neurostimulator devices are few other factors responsible for the high CAGR of the market around the world. However, the high cost of neuromodulation procedures, along with the limited availability of skilled healthcare professionals are the major factors impeding the market growth over the forecast period of 2020-2027.
The regional analysis of the global Neuromodulation market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the early adoption of neuromodulation devices, along with the presence of a significant number of pharmaceutical and biopharmaceutical industries in the region. Whereas Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the increasing prevalence of neurological disorder due to the growing geriatric population, along with the improving healthcare infrastructure in developing nations, such as China and India, would create lucrative growth prospects for the Neuromodulation market across the Asia-Pacific region.
Major market player included in this report are:
Abbott Laboratories
Boston Scientific Corporation
Medtronic PLC
Nevro Corporation
Neuropace Inc.
Neurosigma Inc.
Neuronetics Inc.
LivaNova PLC
Nuvectra
Synapse Biomedical Inc.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Technology:
Internal Neuromodulation
External Neuromodulation
By Application:
Parkinson's Disease
Epilepsy
Depression
Dystonia
Pain Management
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027
Target Audience of the Global Neuromodulation Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
The regional analysis of the global Neuromodulation market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the early adoption of neuromodulation devices, along with the presence of a significant number of pharmaceutical and biopharmaceutical industries in the region. Whereas Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the increasing prevalence of neurological disorder due to the growing geriatric population, along with the improving healthcare infrastructure in developing nations, such as China and India, would create lucrative growth prospects for the Neuromodulation market across the Asia-Pacific region.
Major market player included in this report are:
Abbott Laboratories
Boston Scientific Corporation
Medtronic PLC
Nevro Corporation
Neuropace Inc.
Neurosigma Inc.
Neuronetics Inc.
LivaNova PLC
Nuvectra
Synapse Biomedical Inc.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Technology:
Internal Neuromodulation
External Neuromodulation
By Application:
Parkinson's Disease
Epilepsy
Depression
Dystonia
Pain Management
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027
Target Audience of the Global Neuromodulation Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Neuromodulation Market, by Region, 2018-2027 (USD Billion)
1.2.2. Neuromodulation Market, by Technology, 2018-2027 (USD Billion)
1.2.3. Neuromodulation Market, by Application, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL NEUROMODULATION MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL NEUROMODULATION MARKET DYNAMICS
3.1. Neuromodulation Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
CHAPTER 4. GLOBAL NEUROMODULATION MARKET: INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL NEUROMODULATION MARKET, BY TECHNOLOGY
5.1. Market Snapshot
5.2. Global Neuromodulation Market by Technology, Performance - Potential Analysis
5.3. Global Neuromodulation Market Estimates & Forecasts by Technology 2017-2027 (USD Billion)
5.4. Neuromodulation Market, Sub Segment Analysis
5.4.1. Internal Neuromodulation
5.4.2. External Neuromodulation
CHAPTER 6. GLOBAL NEUROMODULATION MARKET, BY APPLICATION
6.1. Market Snapshot
6.2. Global Neuromodulation Market by Application, Performance - Potential Analysis
6.3. Global Neuromodulation Market Estimates & Forecasts by Application 2017-2027 (USD Billion)
6.4. Neuromodulation Market, Sub Segment Analysis
6.4.1. Parkinson's Disease
6.4.2. Epilepsy
6.4.3. Depression
6.4.4. Dystonia
6.4.5. Pain Management
6.4.6. Others
CHAPTER 7. GLOBAL NEUROMODULATION MARKET, REGIONAL ANALYSIS
7.1. Neuromodulation Market, Regional Market Snapshot
7.2. North America Neuromodulation Market
7.2.1. U.S. Neuromodulation Market
7.2.1.1. Technology breakdown estimates & forecasts, 2017-2027
7.2.1.2. Application breakdown estimates & forecasts, 2017-2027
7.2.2. Canada Neuromodulation Market
7.3. Europe Neuromodulation Market Snapshot
7.3.1. U.K. Neuromodulation Market
7.3.2. Germany Neuromodulation Market
7.3.3. France Neuromodulation Market
7.3.4. Spain Neuromodulation Market
7.3.5. Italy Neuromodulation Market
7.3.6. Rest of Europe Neuromodulation Market
7.4. Asia-Pacific Neuromodulation Market Snapshot
7.4.1. China Neuromodulation Market
7.4.2. India Neuromodulation Market
7.4.3. Japan Neuromodulation Market
7.4.4. Australia Neuromodulation Market
7.4.5. South Korea Neuromodulation Market
7.4.6. Rest of Asia Pacific Neuromodulation Market
7.5. Latin America Neuromodulation Market Snapshot
7.5.1. Brazil Neuromodulation Market
7.5.2. Mexico Neuromodulation Market
7.6. Rest of The World Neuromodulation Market
CHAPTER 8. COMPETITIVE INTELLIGENCE
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Abbott Laboratories
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Boston Scientific Corporation
8.2.3. Medtronic PLC
8.2.4. Nevro Corporation
8.2.5. Neuropace Inc.
8.2.6. Neurosigma Inc.
8.2.7. Neuronetics Inc.
8.2.8. LivaNova PLC
8.2.9. Nuvectra
8.2.10. Synapse Biomedical Inc.
CHAPTER 9. RESEARCH PROCESS
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Neuromodulation Market, by Region, 2018-2027 (USD Billion)
1.2.2. Neuromodulation Market, by Technology, 2018-2027 (USD Billion)
1.2.3. Neuromodulation Market, by Application, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL NEUROMODULATION MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL NEUROMODULATION MARKET DYNAMICS
3.1. Neuromodulation Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
CHAPTER 4. GLOBAL NEUROMODULATION MARKET: INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL NEUROMODULATION MARKET, BY TECHNOLOGY
5.1. Market Snapshot
5.2. Global Neuromodulation Market by Technology, Performance - Potential Analysis
5.3. Global Neuromodulation Market Estimates & Forecasts by Technology 2017-2027 (USD Billion)
5.4. Neuromodulation Market, Sub Segment Analysis
5.4.1. Internal Neuromodulation
5.4.2. External Neuromodulation
CHAPTER 6. GLOBAL NEUROMODULATION MARKET, BY APPLICATION
6.1. Market Snapshot
6.2. Global Neuromodulation Market by Application, Performance - Potential Analysis
6.3. Global Neuromodulation Market Estimates & Forecasts by Application 2017-2027 (USD Billion)
6.4. Neuromodulation Market, Sub Segment Analysis
6.4.1. Parkinson's Disease
6.4.2. Epilepsy
6.4.3. Depression
6.4.4. Dystonia
6.4.5. Pain Management
6.4.6. Others
CHAPTER 7. GLOBAL NEUROMODULATION MARKET, REGIONAL ANALYSIS
7.1. Neuromodulation Market, Regional Market Snapshot
7.2. North America Neuromodulation Market
7.2.1. U.S. Neuromodulation Market
7.2.1.1. Technology breakdown estimates & forecasts, 2017-2027
7.2.1.2. Application breakdown estimates & forecasts, 2017-2027
7.2.2. Canada Neuromodulation Market
7.3. Europe Neuromodulation Market Snapshot
7.3.1. U.K. Neuromodulation Market
7.3.2. Germany Neuromodulation Market
7.3.3. France Neuromodulation Market
7.3.4. Spain Neuromodulation Market
7.3.5. Italy Neuromodulation Market
7.3.6. Rest of Europe Neuromodulation Market
7.4. Asia-Pacific Neuromodulation Market Snapshot
7.4.1. China Neuromodulation Market
7.4.2. India Neuromodulation Market
7.4.3. Japan Neuromodulation Market
7.4.4. Australia Neuromodulation Market
7.4.5. South Korea Neuromodulation Market
7.4.6. Rest of Asia Pacific Neuromodulation Market
7.5. Latin America Neuromodulation Market Snapshot
7.5.1. Brazil Neuromodulation Market
7.5.2. Mexico Neuromodulation Market
7.6. Rest of The World Neuromodulation Market
CHAPTER 8. COMPETITIVE INTELLIGENCE
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Abbott Laboratories
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Boston Scientific Corporation
8.2.3. Medtronic PLC
8.2.4. Nevro Corporation
8.2.5. Neuropace Inc.
8.2.6. Neurosigma Inc.
8.2.7. Neuronetics Inc.
8.2.8. LivaNova PLC
8.2.9. Nuvectra
8.2.10. Synapse Biomedical Inc.
CHAPTER 9. RESEARCH PROCESS
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Neuromodulation market, report scope
TABLE 2. Global Neuromodulation market estimates & forecasts by region 2017-2027 (USD Billion)
TABLE 3. Global Neuromodulation market estimates & forecasts by Technology 2017-2027 (USD Billion)
TABLE 4. Global Neuromodulation market estimates & forecasts by Application 2017-2027 (USD Billion)
TABLE 5. Global Neuromodulation market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 6. Global Neuromodulation market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 7. Global Neuromodulation market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 8. Global Neuromodulation market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 9. Global Neuromodulation market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 10. Global Neuromodulation market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 11. Global Neuromodulation market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 12. Global Neuromodulation market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 13. Global Neuromodulation market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 14. Global Neuromodulation market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 15. Global Neuromodulation market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 16. Global Neuromodulation market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 17. Global Neuromodulation market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 18. Global Neuromodulation market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 19. Global Neuromodulation market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 20. Global Neuromodulation market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 21. U.S. Neuromodulation market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 22. U.S. Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 23. U.S. Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 24. Canada Neuromodulation market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 25. Canada Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 26. Canada Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 27. UK Neuromodulation market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 28. UK Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 29. UK Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 30. Germany Neuromodulation market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 31. Germany Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 32. Germany Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 33. France Neuromodulation market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 34. France Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 35. France Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 36. Spain Neuromodulation market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 37. Spain Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 38. Spain Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 39. Italy Neuromodulation market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 40. Italy Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 41. Italy Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 42. ROE Neuromodulation market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 43. ROE Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 44. ROE Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 45. China Neuromodulation market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 46. China Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 47. China Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 48. India Neuromodulation market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 49. India Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 50. India Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 51. Japan Neuromodulation market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 52. Japan Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 53. Japan Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 54. Australia Neuromodulation market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 55. Australia Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 56. Australia Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 57. South Korea Neuromodulation market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 58. South Korea Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 59. South Korea Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 60. ROPAC Neuromodulation market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 61. ROPAC Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 62. ROPAC Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 63. Brazil Neuromodulation market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 64. Brazil Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 65. Brazil Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 66. Mexico Neuromodulation market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 67. Mexico Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 68. Mexico Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 69. ROLA Neuromodulation market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 70. ROLA Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 71. ROLA Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 72. ROW Neuromodulation market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 73. ROW Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 74. ROW Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 75. List of secondary sources, used in the study of global Neuromodulation market
TABLE 76. List of primary sources, used in the study of global Neuromodulation market
TABLE 77. Years considered for the study
TABLE 78. Exchange rates considered
TABLE 1. Global Neuromodulation market, report scope
TABLE 2. Global Neuromodulation market estimates & forecasts by region 2017-2027 (USD Billion)
TABLE 3. Global Neuromodulation market estimates & forecasts by Technology 2017-2027 (USD Billion)
TABLE 4. Global Neuromodulation market estimates & forecasts by Application 2017-2027 (USD Billion)
TABLE 5. Global Neuromodulation market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 6. Global Neuromodulation market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 7. Global Neuromodulation market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 8. Global Neuromodulation market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 9. Global Neuromodulation market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 10. Global Neuromodulation market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 11. Global Neuromodulation market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 12. Global Neuromodulation market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 13. Global Neuromodulation market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 14. Global Neuromodulation market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 15. Global Neuromodulation market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 16. Global Neuromodulation market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 17. Global Neuromodulation market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 18. Global Neuromodulation market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 19. Global Neuromodulation market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 20. Global Neuromodulation market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 21. U.S. Neuromodulation market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 22. U.S. Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 23. U.S. Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 24. Canada Neuromodulation market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 25. Canada Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 26. Canada Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 27. UK Neuromodulation market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 28. UK Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 29. UK Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 30. Germany Neuromodulation market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 31. Germany Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 32. Germany Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 33. France Neuromodulation market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 34. France Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 35. France Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 36. Spain Neuromodulation market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 37. Spain Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 38. Spain Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 39. Italy Neuromodulation market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 40. Italy Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 41. Italy Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 42. ROE Neuromodulation market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 43. ROE Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 44. ROE Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 45. China Neuromodulation market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 46. China Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 47. China Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 48. India Neuromodulation market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 49. India Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 50. India Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 51. Japan Neuromodulation market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 52. Japan Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 53. Japan Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 54. Australia Neuromodulation market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 55. Australia Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 56. Australia Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 57. South Korea Neuromodulation market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 58. South Korea Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 59. South Korea Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 60. ROPAC Neuromodulation market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 61. ROPAC Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 62. ROPAC Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 63. Brazil Neuromodulation market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 64. Brazil Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 65. Brazil Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 66. Mexico Neuromodulation market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 67. Mexico Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 68. Mexico Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 69. ROLA Neuromodulation market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 70. ROLA Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 71. ROLA Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 72. ROW Neuromodulation market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 73. ROW Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 74. ROW Neuromodulation market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 75. List of secondary sources, used in the study of global Neuromodulation market
TABLE 76. List of primary sources, used in the study of global Neuromodulation market
TABLE 77. Years considered for the study
TABLE 78. Exchange rates considered
LIST OF FIGURES
FIG 1. Global Neuromodulation market, research methodology
FIG 2. Global Neuromodulation market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Neuromodulation market, key trends 2019
FIG 5. Global Neuromodulation market, growth prospects 2020-2027
FIG 6. Global Neuromodulation market, porters 5 force model
FIG 7. Global Neuromodulation market, pest analysis
FIG 8. Global Neuromodulation market, value chain analysis
FIG 9. Global Neuromodulation market by segment, 2017 & 2027 (USD Billion)
FIG 10. Global Neuromodulation market by segment, 2017 & 2027 (USD Billion)
FIG 11. Global Neuromodulation market by segment, 2017 & 2027 (USD Billion)
FIG 12. Global Neuromodulation market by segment, 2017 & 2027 (USD Billion)
FIG 13. Global Neuromodulation market by segment, 2017 & 2027 (USD Billion)
FIG 14. Global Neuromodulation market by segment, 2017 & 2027 (USD Billion)
FIG 15. Global Neuromodulation market by segment, 2017 & 2027 (USD Billion)
FIG 16. Global Neuromodulation market by segment, 2017 & 2027 (USD Billion)
FIG 17. Global Neuromodulation market, regional snapshot 2017 & 2027
FIG 18. North America Neuromodulation market 2017 & 2027 (USD Billion)
FIG 19. Europe Neuromodulation market 2017 & 2027 (USD Billion)
FIG 20. Asia-Pacific Neuromodulation market 2017 & 2027 (USD Billion)
FIG 21. Latin America Neuromodulation market 2017 & 2027 (USD Billion)
FIG 22. Global Neuromodulation market, company market share analysis (2019)
FIG 1. Global Neuromodulation market, research methodology
FIG 2. Global Neuromodulation market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Neuromodulation market, key trends 2019
FIG 5. Global Neuromodulation market, growth prospects 2020-2027
FIG 6. Global Neuromodulation market, porters 5 force model
FIG 7. Global Neuromodulation market, pest analysis
FIG 8. Global Neuromodulation market, value chain analysis
FIG 9. Global Neuromodulation market by segment, 2017 & 2027 (USD Billion)
FIG 10. Global Neuromodulation market by segment, 2017 & 2027 (USD Billion)
FIG 11. Global Neuromodulation market by segment, 2017 & 2027 (USD Billion)
FIG 12. Global Neuromodulation market by segment, 2017 & 2027 (USD Billion)
FIG 13. Global Neuromodulation market by segment, 2017 & 2027 (USD Billion)
FIG 14. Global Neuromodulation market by segment, 2017 & 2027 (USD Billion)
FIG 15. Global Neuromodulation market by segment, 2017 & 2027 (USD Billion)
FIG 16. Global Neuromodulation market by segment, 2017 & 2027 (USD Billion)
FIG 17. Global Neuromodulation market, regional snapshot 2017 & 2027
FIG 18. North America Neuromodulation market 2017 & 2027 (USD Billion)
FIG 19. Europe Neuromodulation market 2017 & 2027 (USD Billion)
FIG 20. Asia-Pacific Neuromodulation market 2017 & 2027 (USD Billion)
FIG 21. Latin America Neuromodulation market 2017 & 2027 (USD Billion)
FIG 22. Global Neuromodulation market, company market share analysis (2019)
